PTC Therapeutics
PTCT
#3028
Rank
C$7.43 B
Marketcap
C$92.61
Share price
-1.77%
Change (1 day)
28.59%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: C$7.43 Billion

As of February 2026 PTC Therapeutics has a market cap of C$7.43 Billion. This makes PTC Therapeutics the world's 3028th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$7.43 B-13.92%
2025C$8.63 B72.56%
2024C$5.00 B81.47%
2023C$2.75 B-27.02%
2022C$3.77 B5.33%
2021C$3.58 B-32.42%
2020C$5.30 B36.67%
2019C$3.88 B64.22%
2018C$2.36 B171.92%
2017C$0.87 B72.92%
2016C$0.50 B-66.99%
2015C$1.52 B-22.87%
2014C$1.97 B359.65%
2013C$0.42 B

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of PTC Therapeutics was reported to be:

C$7.66 Billion
by Nasdaq info icon info icon
C$7.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
C$440.82 B 5,828.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
C$167.71 B 2,155.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$1.16 B-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.71 B-63.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.23 B-96.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
C$15.37 B 106.72%๐Ÿ‡บ๐Ÿ‡ธ USA